Beta Drugs Limited (NSE:BETA)

Beta Drugs Revenue

Beta Drugs had revenue of 1.26B INR in the quarter ending June 30, 2026, with 33.90% growth. This brings the company's total for the last twelve months to 4.10B, up 10.14% year-over-year. In the fiscal year ending March 31, 2026, Beta Drugs had annual revenue of 3.85B with 6.20% growth. That makes Beta Drugs the 28,962nd largest company in the world by revenue and 1,922nd in India.

• Revenue (ttm): 4.10B
• Revenue Growth: +10.14%
• P/S Ratio: 4.87
• Revenue / Employee: 9.01M
• Employees: 455
• Market Cap: 19.93B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• India 3.14B 81.6%
• Export 708.70M 18.4%

Fiscal year ended Mar 31, 2026 See the full Beta Drugs breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	3.85B	224.70M	6.20%
Mar 31, 2025	3.62B	666.42M	22.54%
Mar 31, 2024	2.96B	686.00M	30.21%
Mar 31, 2023	2.27B	432.76M	23.54%
Mar 31, 2022	1.84B	677.16M	58.31%

Data Source: S&P Global Market Intelligence Last updated: Jul 20, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error